2026, Volume 33, Supplement 1:
UNSEEN AND UNHEARD: Addressing Barriers in Diagnostic and Treatment Inequalities for p.V142I hATTR-CM in Black Communities
Sponsorship statement: The development of this white paper was organised and fully funded by Pfizer Ltd. Pfizer Ltd also organised and funded the publication of this work as a supplement to the British Journal of Cardiology.
PP-UNP-GBR-14528 | May 2026
